<div class="table-container">
<table class="table1">
<thead>
<tr>
<th  colspan="6" data-col="0" style="text-align: center; background-color: #d0e5f5;"><button class="hide-col-btn" onclick="toggleColumn(0)">✖</button>
<strong>Heme-Onc Gene Mutations Summary</strong>
</th>
</tr>
<tr>
<th data-col="0" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(0)">✖</button>Disease</th>
<th data-col="1" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(1)">✖</button>Gene / Mutation</th>
<th data-col="2" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(2)">✖</button>Cytogenetics</th>
<th data-col="3" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(3)">✖</button>Mechanism</th>
<th data-col="4" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(4)">✖</button>Category</th>
<th  data-col="5" style="background-color: #f7f9fa;"><button class="hide-col-btn" onclick="toggleColumn(5)">✖</button>Lineage</th>
</tr>
</thead>
<tbody>
<tr><td data-col="0">Chronic Myeloid Leukemia (CML)</td><td data-col="1">BCR-ABL fusion</td><td data-col="2">t(9;22), Philadelphia chromosome</td><td data-col="3">Oncogene activation</td><td data-col="4">Oncogene</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Acute Promyelocytic Leukemia (APL)</td><td data-col="1">PML-RARA fusion</td><td data-col="2">t(15;17)</td><td data-col="3">Oncogene activation</td><td data-col="4">Oncogene</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Burkitt Lymphoma</td><td data-col="1">MYC translocation</td><td data-col="2">t(8;14)</td><td data-col="3">Oncogene activation</td><td data-col="4">Oncogene</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Mantle Cell Lymphoma</td><td data-col="1">Cyclin D1 (CCND1) translocation</td><td data-col="2">t(11;14)</td><td data-col="3">Oncogene activation</td><td data-col="4">Oncogene</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Follicular Lymphoma</td><td data-col="1">BCL2 translocation</td><td data-col="2">t(14;18)</td><td data-col="3">Apoptosis inhibition</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Diffuse Large B-Cell Lymphoma</td><td data-col="1">BCL6 mutations</td><td data-col="2">various</td><td data-col="3">Oncogene activation</td><td data-col="4">Oncogene</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Hairy Cell Leukemia</td><td data-col="1">BRAF V600E mutation</td><td data-col="2">point mutation</td><td data-col="3">MAPK pathway activation</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Acute Lymphoblastic Leukemia (ALL)</td><td data-col="1">TEL-AML1, BCR-ABL</td><td data-col="2">various</td><td data-col="3">Fusion oncogenes</td><td data-col="4">Oncogene</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">T-ALL</td><td data-col="1">NOTCH1 gain-of-function</td><td data-col="2">point mutation</td><td data-col="3">T-cell proliferation</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Chronic Lymphocytic Leukemia (CLL)</td><td data-col="1">Deletion 13q14</td><td data-col="2">del(13q)</td><td data-col="3">Tumor suppressor loss</td><td data-col="4">Tumor Suppressor</td><td  data-col="5">Lymphoid</td></tr>
<tr><td data-col="0">Multiple Myeloma</td><td data-col="1">Deletion 17p (TP53)</td><td data-col="2">del(17p)</td><td data-col="3">Tumor suppressor loss</td><td data-col="4">Tumor Suppressor</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Myelodysplastic Syndromes (MDS)</td><td data-col="1">Deletion 5q</td><td data-col="2">del(5q)</td><td data-col="3">Tumor suppressor loss</td><td data-col="4">Tumor Suppressor</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Polycythemia Vera</td><td data-col="1"><b>JAK2</b> V617F</td><td data-col="2">point mutation</td><td data-col="3">Tyrosine kinase activation</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Essential Thrombocythemia</td><td data-col="1"><b>JAK2</b>, CALR, MPL</td><td data-col="2">point mutations</td><td data-col="3">Signal transduction</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Primary Myelofibrosis</td><td data-col="1"><b>JAK2</b>, CALR, MPL</td><td data-col="2">point mutations</td><td data-col="3">Signal transduction</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Myeloid</td></tr>
<tr><td data-col="0">Hemochromatosis</td><td data-col="1">HFE mutation</td><td data-col="2">Chromosome 6p21.3</td><td data-col="3">Iron overload disorder (non-oncogenic)</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Sickle Cell Disease</td><td data-col="1">HBB gene mutation (Glu6Val)</td><td data-col="2">Chromosome 11p15.5</td><td data-col="3">Structural hemoglobinopathy</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Thalassemia (alpha)</td><td data-col="1">HBA1, HBA2 deletions</td><td data-col="2">Chromosome 16</td><td data-col="3">Reduced alpha-globin synthesis</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Thalassemia (beta)</td><td data-col="1">HBB point mutations</td><td data-col="2">Chromosome 11</td><td data-col="3">Reduced beta-globin synthesis</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">G6PD Deficiency</td><td data-col="1">G6PD mutation</td><td data-col="2">Xq28</td><td data-col="3">Enzymopathy – hemolytic anemia</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Hereditary Spherocytosis</td><td data-col="1">ANK1, SPTB, SPTA1, EPB42</td><td data-col="2">Various</td><td data-col="3">Membrane defect (non-oncogenic)</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Fanconi Anemia</td><td data-col="1">FANC genes</td><td data-col="2">Various</td><td data-col="3">DNA repair defect – pancytopenia, ↑ cancer risk</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
<tr><td data-col="0">Paroxysmal Nocturnal Hemoglobinuria</td><td data-col="1">PIGA mutation</td><td data-col="2">X chromosome</td><td data-col="3">Complement regulation defect</td><td data-col="4">Non-Oncogenic</td><td  data-col="5">Other</td></tr>
</tbody>
</table>
</div>